Blockbuster weight loss and diabetes drugs may lower patients’ risk of developing some common types of cancer that are closely linked to obesity, new evidence suggests. Patients with Type 2 diabetes who were prescribed drugs known as glucagon-like peptide-1, or GLP-1, developed fewer obesity-related cancers than patients who were treated with insulin, according to a study published Friday in JAMA Network Open. But the newer drugs didn’t perform better than metformin, an older diabetes drug with known cancer risk reduction properties. [time-brightcove not-tgx=”true”] The group of drugs the study looked at includes Novo Nordisk A/S’s Ozempic, a diabetes treatment. Since the stud
Hence then, the article about drugs like ozempic are linked to a lower cancer risk was published today ( ) and is available onTime ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Drugs Like Ozempic Are Linked to a Lower Cancer Risk )